Life Sciences Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program AIT News Desk Jun 27, 2022 Vir Biotechnology, Inc. announced new data from its robust hepatitis B virus (HBV) clinical trial program, including results from an ongoing Phase 2…
Life Sciences New Testing Methods Help Ease Diagnostic Burdens in Healthcare AIT News Desk Aug 11, 2020 As healthcare systems come under severe pressure from the pandemic, significant changes to their infrastructure are required. In particular,…